Tech Company Financing Transactions
4C Medical Funding Round
Boston Scientific Corporation and private investors participated in a $175 million Series D venture round for 4C Medical. The round was announced on 3/5/2025.
Transaction Overview
Company Name
Announced On
3/5/2025
Transaction Type
Venture Equity
Amount
$175,000,000
Round
Series D
Investors
Boston Scientific Corporation (Lead Investor)
Proceeds Purpose
The financing will be utilized to accelerate the clinical development and commercialization of the AltaValve� System, the company's next generation transcatheter mitral valve replacement (TMVR) technology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6655 Wedgwood Rd. Suite 160
Maple Grove, MN 55311
USA
Maple Grove, MN 55311
USA
Phone
Website
Email Address
Not Recorded
Overview
4C Medical is a medical device company developing minimally invasive technologies for structural heart disease, focusing initially on mitral regurgitation (MR) therapy and subsequently on tricuspid regurgitation therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jeffrey Chambers
Chief Executive Officer
Saravana Kumar
Chief Financial Officer
Scott Youngstrom
Browse more venture capital transactions:
Prev: 3/5/2025: Notify Technologies venture capital transaction
Next: 3/5/2025: GoodSAM Foods venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs